AzTrials
AzTrials

Hip FracturesENHANCENCT06286722

Optimized Rehabilitation of Older Adults With Hip Fracture and Signs of Cognitive Impairment - Feasibility Study

A study testing Progressive, individualized and structured exercise program in people with Hip Fractures and Cognitive Impairment, run by Lolland Community, Denmark at 6 sites in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Older adults suffering from a hip fracture are a significant concern, with higher incidence rates among women. Mortality rates post-hip fracture are alarming, with up to 8-fold increased risk within 3 months and significant percentages within 30 days and 12 months. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Hip Fractures, Cognitive Impairment
What is being tested?
Progressive, individualized and structured exercise program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
6 sitesDenmark
Study dates
8 Feb 2024to 30 Jun 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Recently (within 3 weeks) underwent surgical repair of a hip fracture (femoral neck or trochanteric fracture)
  • Independent pre-fracture ambulatory function (≥2 on the New Mobility Score on indoor walking)
  • Having signs of cognitive impairment measured with the Mini-Mental Score Examination of <24 points, or a verified dementia diagnosis, or on information from the patient record
  • Living in their own home, nursing home, or assisted living facilities
  • Informed consent by patient

Who cannot join

  • Pathological hip fracture
  • Having signs of severe dementia measured with the Mini-Mental State Examination (<10 points)
  • Non-Danish speaking
  • Patients with an unstable health condition (e.g. not treated high blood pressure (>180 mm HG)) evaluated by medical consultant
  • "Safety concerns" (e.g. underlying comorbidities that might be associated with serious adverse events) - not safe to participate in the opinion of the investigator
  • Having behavioral or psychotic disorders
Show all 9Show fewer
  • Alcohol or drug abuse
  • Unable to participate in the intervention (e.g. due to blindness, no language)
  • Patients with any weight-bearing restrictions after surgery

Trial locations and contacts

6 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Jan Arnholtz Overgaard, MSc. contact

+4561121191

jover@lolland.dk

Søren Thorgaard Skou, PhD contact

004523708640

stskou@health.sdu.dk

6 sites in 1 country

Denmark6 sites, 6 recruiting
  • Frederiksberg Healthcare center and 24-hour rehabilitation

    Frederiksberg, 2000

    Nanna Aue Sobol, PT, PhD, jover@lolland.dk

    Recruiting
  • Stevns Healthcare Center, Stevns Municipality

    Hårlev, 4652

    Lotte Bylov, jover@lolland.dk

    Recruiting
  • Hørsholm Health and Rehabilitation Center

    Hørsholm, 2970

    Niklas Grundt Hansen, PT, MSc., jover@lolland.dk

    Recruiting
  • Maribo Health Center, Lolland Municipality

    Maribo, 4930

    Jan Arnholtz Overgaard, MSc., +4554677700, jover@lolland.dk

    Gwen Tremmel, +4554677700, gptr@lolland.dk

    Recruiting
  • Guldborgsund Healthcare Center, Guldborgsund Municipality

    Nykøbing Falster, 4800

    Jakob Jensen, PT, jover@lolland.dk

    Recruiting
  • Vordingborg Healthcare Center, Vordingborg Municipality

    Vordingborg, 4760

    Line Flemmer, Bachelor, jover@lolland.dk

    Recruiting

Other trials in Denmark

About this study

Official title: Optimized Rehabilitation of Older Adults With Hip Fracture and Signs of Cognitive Impairment - the ENHANCE Project - Feasibility Study

Older adults suffering from a hip fracture are a significant concern, with higher incidence rates among women. Mortality rates post-hip fracture are alarming, with up to 8-fold increased risk within 3 months and significant percentages within 30 days and 12 months. Older adults with hip fracture face challenges in regaining pre-fracture level of function, especially those with cognitive impairment, which affects 25% to 40% of cases and increases mortality risk. While interventions exist, such as progressive strength training and structured exercise programs, patients with hip fracture don't consistently restore pre-fracture function, particularly in cognitively impaired patients, who are often excluded from studies. Limited evidence exists on effective management for this subgroup, with a lack of clarity on community-based rehabilitation. Although guidelines suggest exercise interventions for patients with mild to moderate cognitive impairment, the specifics remain uncertain due to insufficient research focused solely on this population.

This feasibility study aims to assess the practicality and safety of implementing a 12-week individualized, progressive exercise program for older adults with hip fracture and cognitive impairment in an outpatient setting. Additionally, the investigators seek to gather qualitative insights through observations and interviews regarding participants' experiences and the perceived value of rehabilitation post-hip fracture, particularly focusing on the exercise intervention provided.

Read the detailed description

Background and overall aim. Approximately 7,000 people suffer a hip fracture in Denmark each year. A hip fracture is a traumatic event with high mortality rates, and older adults with hip fractures experience significant pain, a general decline in functional ability, and difficulty regaining the same level of function (e.g., being able to move freely without walking aids) as before the fracture. Older adults with hip fracture and signs of cognitive impairment constitute a subgroup, accounting for 25-40% of the total group. Dementia increases the likelihood of sustaining a hip fracture nearly threefold and results in higher mortality rates compared to the rest of the patient group. Furthermore, many individuals do not receive the treatment/training they are entitled to, despite being initially worse off than those without signs of cognitive impairment. There is limited research in this area because older adults with signs of cognitive impairment are often excluded from research studies. The few studies available suggest that older adults with hip fracture and signs of cognitive impairment may benefit from the same interventions provided to older adults with hip fracture who do not have signs of cognitive impairment. However, no randomized controlled trials have been conducted to investigate whether a systematic, well-planned, and personalized home training program is superior to the standard training offered in municipalities for older adults with hip fracture and signs of cognitive impairment. With this feasibility study it is intended to assess the practicality and safety of a 12-week individualized, progressive exercise program for older adults with hip fracture and signs of cognitive impairment in a municipality-based setting shortly after discharge from hospital. Hopefully, and if there are positive results from this feasibility study the investigators will proceed with a randomized controlled trial (in another study).

Being tested
Progressive, individualized and structured exercise program
Keywords
Outpatient, Rehabilitation, Progressive, structured exercise, Hip Fracture, Cognitive impairment, Older adults
Medical subject headings
Hip Fractures, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Progressive, individualized and structured exercise programOther

    See description under Arms

Study groups in NCT06286722
Study groupRoleWhat they receive
Progressive, individualized and structured exercise programExperimentalIndividualized, progressive, structured exercise program. Participants will receive 12-weeks of either home-based and/or at a healthcare center intervention. The "at home" intervention will consist of 3 visits/sessions per week (approximately 30-60 min.) for 12 weeks (maximum of 36 sessions in total) delivered in the participants own home, temporary home (e.g. 24- hour rehabilitation facility), nursing home or assisted living facilities. The "at a healthcare center" intervention will be suggested to the participant when the physiotherapist and the participant feel confident that the participant can handle the transportation to/from the healthcare center, and will benefit from the higher intensity of the "at a healthcare center" intervention. This intervention consists of 2 visits/sessions per week (approximately 45-60 min.) for 12 weeks (total maximum of 24 sessions).
Receives: Other: Progressive, individualized and structured exercise program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The New Mobility Score

    The New Mobility Score is a composite score of the participant's ability to perform: indoor walking, outdoor walking and shopping, providing a score between zero and three (0: not at all, 1: with help from another person, 2: with an aid, 3: no difficulty) for each function, resulting in a total score from 0 to 9, with nine indicating a high functional level.

    Measured: Baseline, 3 months, 6 months

Secondary outcomes (14)
  1. Mini Mental State Examination

    A test to assess a participants cognitive level from a score from 0 to 30 points. A Mini-Mental State Examination can be used to check for cognitive impairment. The maximum score is 30 points. A score of 25 or higher is classed as normal. If the score is below 24, the result is usually considered to be abnormal, indicating possible cognitive impairment.

    Measured: Baseline and 6 months

  2. Height

    To assess the participants height in meters

    Measured: Baseline

  3. Weight

    To assess the participants weight in kilograms

    Measured: Baseline, 3 months, 6 months

  4. Tandem balance test

    A static balance test scoring the participants ability to stand in 3 different positions (0-30 point, where 30 points indicating no balance problem to 0 points = having seriously balance problems)

    Measured: Baseline, 3 months, 6 months

  5. The Barthel-20

    To assess basic activities of daily living functions with the Barthel-20 test. Total possible scores range from 0-20, with lower scores indicating increased disability and higher score indicating independency.

    Measured: Baseline, 3 months, 6 months

  6. 30 sec chair raise test

    This test examines the participants ability to raise up from a chair for as many times as possible within 30 seconds

    Measured: Baseline, 3 months, 6 months

  7. Brief Assessment of Impaired Cognition Questionaire

    A test to evaluate the participants cognitive level with a score ranging from 0 (= serious cognitive problems) to 20 point (= no impaired cognition).

    Measured: Baseline, 3 months, 6 months

  8. Handgrip strength measurement

    An assessment of the participants handgrip strength with a handheld grip strength dynamometer.

    Measured: Baseline, 3 months, 6 months

  9. The Cumulated Ambulation Score

    This score describes the participants independence in three activities (getting in and out of bed, sit-to-stand-to-sit from a chair, and walking). Each activity is assessed from 0-2 (0 = Not able to, despite human assistance and verbal cueing, 1 = Able to, with human assistance and/or verbal cueing from one or more persons, 2 = Able to safely, without human assistance or verbal cueing, use of a walking aid allowed). Total score ranging from zero to six points

    Measured: Baseline, 3 months, 6 months

  10. Four meter walk test

    To assess the participants gait speed over 4 meter walk.

    Measured: Baseline, 3 months, 6 months

  11. Euroqol 5 dimensions

    The Euroqol 5 dimensions essentially consists of 2 overall items; a descriptive system and the Euroqol visual analogue scale. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.

    The Euroqol visual analog scale records the patient's self-rated health on a vertical visual analogue scale ranging from 0 to 100 with endpoints labelled 'The best health you can image' (= 100) and 'The worst health you can image' (= 0). The visual analog scale can be used as a quantitative measure of health outcome that reflects the patient's own judgement.

    Measured: Baseline, 3 months, 6 months

  12. Clinical Frailty Scale

    The Clinical Frailty Scale is a 9-point scale (ranging from 1 to 9) to summarize the overall level of fitness or frailty of an participant after they have been evaluated by a health care professional. The Clinical Frailty Scale is scored so that higher scores mean greater risk/frailty.

    Measured: Baseline, 3 months, 6 months

  13. The Verbal Rating Scale

    To assess the level of hip fracture-related pain using a 5 point scale (0 = no pain, 1 = light pain, 2 = moderate pain, 3 = severe pain, 4 = intolerable pain) in participants with hip fracture.

    Measured: Baseline, 3 months, 6 months

  14. Activity accelerometers

    To measure the amount of physical activity within 7 days. The two accelerometers (one placed on the wrist, the other on the thigh) will be monitor the participants activity level for 7 continous days (24 H a day).

    Measured: Baseline, 3 months, 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Feb 2024
  2. Study start8 Feb 2024
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion30 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Feasibility study
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06286722
Sponsor's protocol ID
LollandCD
Acronym
ENHANCE
Status last verified
Feb 2025
First submitted
7 Feb 2024
Last updated
12 Feb 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Progressive, individualized and structured exercise program in people with Hip Fractures and Cognitive Impairment, run by Lolland Community, Denmark at 6 sites in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jan Arnholtz Overgaard, MSc. (+4561121191, jover@lolland.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The New Mobility Score (time frame: Baseline, 3 months, 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in